Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer

References

• Bremnes RM, Busund L-T, Kilvaer TL, et al. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer. J Thorac Oncol. 2016;11(6):789–800. doi:10.1016/j.jtho.2016.01.01526845192
   PubMed Web of Science ®Google Scholar
• Castellanos-Rizaldos E, Grimm DG, Tadigotla V, et al. Exosome-based detection of EGFR T790M in plasma from non-small cell lung cancer patients. Clin Cancer Res. 2018;24(12):2944–2950. doi:10.1158/1078-0432.CCR-17-336929535126
   PubMed Web of Science ®Google Scholar
• Hu SY, Huang KM, Adams EJ, Loprinzi CL, Lustberg MB. Recent developments of novel pharmacologic therapeutics for prevention of chemotherapy-induced peripheral neuropathy. Clin Cancer Res. 2019;25(21):6295–6301. doi:10.1158/1078-0432.CCR-18-215231123053
   PubMed Web of Science ®Google Scholar
• Shankar S, Ganapathy S, Srivastava RK. Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci. 2007;12:4881–4899. doi:10.2741/243517569617
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009;9(6):429–439. doi:10.1038/nrc264119472429
   PubMed Web of Science ®Google Scholar
• Zhang LZ, Xie J, Gan RH, et al. Synergistic inhibition of lung cancer cells by EGCG and NF-kB inhibitor BAY11-7082. J Cancer. 2019;10(26):6543–6556. doi:10.7150/jca.3428531777584
   PubMed Web of Science ®Google Scholar
• Bailey HH, Mukhtar H, Almoustafa HA, Alshawsh MA, Chik Z. Green tea polyphenols and cancer chemoprevention of genitourinary cancer. Am Soc Clin Oncol Educ Book. 2014;287:92–96. doi:10.1200/EdBook_AM.2013.33.92
   Google Scholar
• Khan N, Mukhtar H. Tea and health: studies in humans. Curr Pharm Des. 2013;19:6141–6147. doi:10.2174/138161281131934000823448443
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Tarapore RS, Mukhtar H. Prevention of skin cancer by green tea: past, present and future. Cancer Biol Ther. 2009;8:1288–1291. doi:10.4161/cbt.8.13.902219556855
   PubMed Web of Science ®Google Scholar
• Butt MS, Sultan MT. Green tea: nature’s defense against malignancies. Crit Rev Food Sci. 2009;49:463–473. doi:10.1080/10408390802145310
   PubMed Web of Science ®Google Scholar
• Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009;14:226–246.19803548
   PubMed Web of Science ®Google Scholar
• Hsieh DS, Wang H, Tan S-W, et al. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Biomaterials. 2011;32(30):7633–7640. doi:10.1016/j.biomaterials.2011.06.07321782236
   PubMed Web of Science ®Google Scholar
• Du GJ, Zhang ZY, Wen XD, et al. Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients. 2012;4(11):1679–1691. doi:10.3390/nu411167923201840
   PubMed Web of Science ®Google Scholar
• Luo KW, Chen W, Lung WY, et al. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. J Nutr Biochem. 2017;41:56–64. doi:10.1016/j.jnutbio.2016.12.00428040581
   PubMed Web of Science ®Google Scholar
• Nie S, Emory SR. Probing single molecules and single nanoparticles by surface-enhanced raman scattering. Science. 1997;275(5303):1102–1106. doi:10.1126/science.275.5303.11029027306
   PubMed Web of Science ®Google Scholar
• Rosi NL, Giljohann DA, Thaxton CS, et al. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science. 2006;312(5776):1027–1030. doi:10.1126/science.112555916709779
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long circulating polymeric nanospheres. Science. 1994;263:1600–1603. doi:10.1126/science.81282458128245
   PubMed Web of Science ®Google Scholar
• Blakely CM, Pazarentzos E, Krogan NJ, Bivona TG. NF-kB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer. Cell Rep. 2015;11:98–110. doi:10.1016/j.celrep.2015.03.01225843712
   PubMed Web of Science ®Google Scholar
• Safer AM, Leporatti S, Jose J, Soliman MS. Conjugation of EGCG and chitosan NPs as a novel nano-drug delivery system. Int J Nanomedicine. 2019;14:8033–8046. doi:10.2147/IJN.S21789831632016
   PubMed Web of Science ®Google Scholar
• Su JQ, Guo Q, Chen YL, Mao L, Gao YX, Yuan F. Utilization of β-lactoglobulin- (−)-epigallocatechin- 3-gallate(EGCG) composite colloidal nanoparticles as stabilizers for lutein pickering emulsion. Food Hyd. 2020;98:105293. doi:10.1016/j.foodhyd.2019.105293
   Web of Science ®Google Scholar
• Wu SC, Yang XR, Luo FH, et al. Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery. J Nanobiotechnol. 2018;90:1575–1590.
   Google Scholar
• Ringsdrorf H. Structure and properties of pharmacologically active polymers. J Polym Sci Polymer Symp. 1975;51:135–153. doi:10.1002/polc.5070510111
   Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505–522. doi:10.1016/j.jconrel.2012.01.04322353619
   PubMed Web of Science ®Google Scholar
• Varypataki EM, Silva AL, Barnier-Quer C, Collin N, Ossendorp F, Jiskoot W. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: a comparative study of cationic liposomes and PLGA nanoparticles. J Control Release. 2016;226:98–106. doi:10.1016/j.jconrel.2016.02.01826876760
   PubMed Web of Science ®Google Scholar
• Lu B, Lv X, Le Y. Chitosan-modified PLGA nanoparticles for control-released drug delivery. Polymers. 2019;11(2):304. doi:10.3390/polym11020304
   PubMed Web of Science ®Google Scholar
• Zou J, Yang Y, Liu XR. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway. Biomed Pharmacother. 2018;108:130–136. doi:10.1016/j.biopha.2018.09.05130218857
   PubMed Web of Science ®Google Scholar
• Fox ME, Szoka FC, Frechet JM. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res. 2009;42:1141–1151. doi:10.1021/ar900035f19555070
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics. 2014;4:81–89. doi:10.7150/thno.7193
   Web of Science ®Google Scholar
• Chen MS, Ouyang HC, Zhou SY, Li JY, Ye YB. PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses. Cell Immunol. 2014;287:91–99. doi:10.1016/j.cellimm.2014.01.00324487032
   PubMed Web of Science ®Google Scholar
• Almoustafa HA, Alshawsh MA, Chik Z. Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method. Int J Pharm. 2017;533:275–284. doi:10.1016/j.ijpharm.2017.09.05428943210
   PubMedGoogle Scholar
• Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 2009;30:2790–2798. doi:10.1016/j.biomaterials.2009.01.05719232712
   PubMed Web of Science ®Google Scholar
• Ngoc TV, Park MA, Shultz MD, Bulut GB, Ladd AC, Chalfant CE. Caspase-9b interacts directly with cIAP1 to drive agonist-independent activation of NF- B and lung tumorigenesis. Cancer Res. 2016;76(10):2977–2989. doi:10.1158/0008-5472.CAN-15-251227197231
   PubMed Web of Science ®Google Scholar
• Chen YC, Zhang R, Wang L, et al. Tumor characteristics associated with engraftment of patient-derived non–small cell lung cancer xenografts in immunocompromised mice. Cancer. 2019;125(21):3738–3748. doi:10.1002/cncr.3236631287557
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Adhami VM, Bharali DJ, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 2009;69:1712–1716. doi:10.1158/0008-5472.CAN-08-397819223530
   PubMed Web of Science ®Google Scholar
• Khan N, Bharali DJ, Adhami VM, et al. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis. 2014;35:415–423. doi:10.1093/carcin/bgt32124072771
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Adhami VM, Chamcheu JC, Mukhtar H. Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine. 2012;7:591–605. doi:10.2147/IJN.S2602622346353
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer. 2010;62:883–890. doi:10.1080/01635581.2010.50953720924964
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Mukhtar H. Nanochemoprevention by bioactive food components: a perspective. Pharm Res Dordr. 2010;27:1054–1060. doi:10.1007/s11095-010-0087-9
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Call TG, Zent CS, et al. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, rai stage 0 to II chronic lymphocytic leukemia. Cancer. 2013;119:36370. doi:10.1002/cncr.27719
   Web of Science ®Google Scholar
• Stingl JC, Ettrich T, Muche R, et al. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer. 2011;11:360. doi:10.1186/1471-2407-11-36021851602
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009;66:2873–2896. doi:10.1007/s00018-009-0053-z19499185
   PubMed Web of Science ®Google Scholar
• Singhal S, Vachani A, Ozerkis AD, et al. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res. 2005;11:3974–3986. doi:10.1158/1078-0432.CCR-04-266115930332
   PubMed Web of Science ®Google Scholar
• Pires BR, Silva RCM, Ferreira GM, Abdelhay E. NF-kappaB: two sides of the same coin. Genes. 2018;9:24. doi:10.3390/genes9010024
   PubMed Web of Science ®Google Scholar
• Zheng DL. Orthotopic tumours, a hot topic for xenograft models? EBioMedicine. 2019;41:11–12. doi:10.1016/j.ebiom.2019.02.05230833189
   PubMed Web of Science ®Google Scholar
• Jin G, Yang Y, Liu K, et al. Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway. Oncogenesis. 2017;6:1–12. doi:10.1038/oncsis.2017.84
   Web of Science ®Google Scholar
• Banerjee SS, Aher N, Patil R, Khandare J. Poly (ethylene glycol) prodrug conjugates: concept, design, and applications. J Drug Deliv. 2012;2012:103973. doi:10.1155/2012/10397322645686
   PubMedGoogle Scholar
• Yoo JW, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev. 2011;63:1247–1256. doi:10.1016/j.addr.2011.05.00421605607
   PubMed Web of Science ®Google Scholar
• Fahmy TM, Fong PM, Goyal A, Saltzman WM. Targeted for drug delivery. Mater Today. 2005;8:18–26. doi:10.1016/S1369-7021(05)71033-6
   Web of Science ®Google Scholar
• Stella B, Arpicco S, Peracchia MT, et al. Synthesis and multidisciplinary characterization of polyelectrolyte multilayer-coated nanogold with improved stability toward aggregation. Colloid Polym Sci. 2011;289:269–280. doi:10.1007/s00396-010-2343-2
   Web of Science ®Google Scholar
• Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release. 2007;120:18–26. doi:10.1016/j.jconrel.2007.03.01217509712
   PubMed Web of Science ®Google Scholar